Navigation Links
Two New Strategic Reports Expand Coverage Of BioTrend's Biosimilars Advisory Service
Date:4/1/2013

EXTON, Pa., April 1, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, has released two strategic components to its 2013 Biosimilars Advisory Service, which provides vital business planning insights and analysis in the evolving biosimilars space. The reports entitled Corporate Strategies and Global Pipelines, Pathways and Key Stakeholder Perspectives of Biosimilars analyze surveyed opinions of specialist physicians and payers in the United States and Europe and secondary market research to uncover critical trends in strategic development for commercially lucrative market segments.

"The Biosimilars Advisory Service has always been a highly valuable tool for understanding trends in a complex and dynamic market," said Andrew Merron , Ph.D., Senior Director, Biosimilars Research at Decision Resources Group. "These new reports aim to enhance the overall service by evaluating current market opinion to help understand globally focused business strategies, regulatory guidance in multiple markets and pipeline information."

BioTrends Research Group's Biosimilars Advisory Service also includes quarterly webinars detailing major industry developments, analyst insight addressing key market changes, therapeutic area-specific primary research and interactive annualized 10-year forecasts.

About BioTrends Research Group
BioTrends Research Group provides syndicated and custom primary market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please visit www.Bio-Trends.com. BioTrends is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

 For more information, contact:BioTrends Research Group Decision Resources GroupAllison Thrower

Liz Marshall781-993-2604

781-993-2563athrower@dresourcesgroup.com

emarshall@dresourcesgroup.com


'/>"/>
SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Neuro Intervention Market: New Strategic Landscape & Market Forecast
2. MDHI Receives Strategic Investment to Continue Strong Growth - Moves into Positive Operating Cash Flow for March 2013 Quarter
3. Saladax Biomedical Receives $22.4 Million Strategic Equity Investment From Shanghai Fosun Pharmaceutical
4. DDS Lab Announces Strategic Alliance with United Concordia
5. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
6. Evofem Announces Strategic Alliance with WomanCare Global
7. WebMD and Qualcomm Life Launch Strategic mHealth Collaboration
8. Imalux Corporation Engages Advisor to Explore Strategic Options
9. BioDrain Medical Retains KCSA Strategic Communications as Corporate Communications Counsel
10. Mylan Enhances Partnership with Biocon through Strategic Collaboration for Insulin Products
11. Covaris and HORIBA Instruments Form Strategic Relationship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition of ... to their offering. ... IPF pipeline is very strong with a total of 97 drug candidates. ... and Sanofi are involved in the development of the IPF therapeutics. The ... Phase III stage, 15 are in Phase II stage, 12 are in ...
(Date:3/24/2017)... March 24, 2017 Global Ampoules ... including definitions, classifications, applications and industry chain structure. The ... including development history, competitive landscape analysis, and major regions, ... ... across 105 pages providing 10 company profiles and 183 ...
(Date:3/24/2017)... 24, 2017  GenomeDx Biosciences today announced that six ... Decipher® Prostate Cancer Classifier tests will be presented at ... (EAU) Congress held March 24 to 28, 2017 in ... Congress is Europe,s largest urological ... the urological field. The abstract titled "Muscle ...
Breaking Medicine Technology:
(Date:3/23/2017)... Seattle, WA (PRWEB) , ... March 23, 2017 , ... ... emergency and now estimates that there could be four million Zika-related cases in the ... to date with numbers of US cases reported per year skyrocketing to an estimated ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating their commitment to ... public health departments have been awarded national accreditation through the Public Health ... the expanding network of communities across the nation whose health departments meet rigorous ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is revolutionizing the ... huge impact on businesses and individual consumers alike. Laboratories can maximize their profit ... value anywhere from $4 trillion to $11 trillion dollars by the year 2025. McKinsey ...
(Date:3/23/2017)... ... March 23, 2017 , ... Dilger-Maxwell ... of the Norwalk and Vermillion areas, celebrates the newest charity campaign in ... nonprofit, community-based substance abuse prevention and peer recovery support organization providing vital ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Management Accreditation from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, ... status is granted to organizations that have excellent programs for the delivery and ...
Breaking Medicine News(10 mins):